Ramipril/HCTZ Krka 5 mg - 25 mg comp. Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ramipril/hctz krka 5 mg - 25 mg comp.

krka d.d. novo mesto d.d. - hydrochlorothiazide 25 mg; ramipril 5 mg - comprimé - 5 mg - 25 mg - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics

Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12,5 mg Lactab Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-amlodipin-hct-mepha 20 mg/5 mg/12,5 mg lactab

mepha pharma ag - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - lactab - filmtablette: olmesartanum medoxomilum 20 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 19 mg, crospovidonum povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.21 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/12,5 mg Lactab Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-amlodipin-hct-mepha 40 mg/5 mg/12,5 mg lactab

mepha pharma ag - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - lactab - filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, e 172 (flavum), macrogolum 4000, talcum, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-Amlodipin-HCT-Mepha 40 mg/10 mg/12,5 mg Lactab Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-amlodipin-hct-mepha 40 mg/10 mg/12,5 mg lactab

mepha pharma ag - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - lactab - filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 10 mg ut amlodipini besilas 13.86 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, e 172 (rubrum), macrogolum 4000, talcum, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/25 mg Lactab Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-amlodipin-hct-mepha 40 mg/5 mg/25 mg lactab

mepha pharma ag - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - lactab - filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, e 172 (flavum), macrogolum 4000, talcum, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-Amlodipin-HCT-Mepha 40 mg/10 mg/25 mg Lactab Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-amlodipin-hct-mepha 40 mg/10 mg/25 mg lactab

mepha pharma ag - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - lactab - filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 10 mg ut amlodipini besilas 13.86 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum k 30, carboxymethylamylum natricum a corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, e 172 (rubrum), macrogolum 4000, talcum, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-HCT-Mepha Teva 20/12.5 mg Comprimés pelliculés Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 20/12.5 mg comprimés pelliculés

mepha pharma ag - hydrochlorothiazidum - comprimés pelliculés - olmesartanum medoxomilum 20.0 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 138.55 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 1.386 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), e 110 0.003 mg, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-HCT-Mepha Teva 20/25 mg Comprimés pelliculés Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 20/25 mg comprimés pelliculés

mepha pharma ag - hydrochlorothiazidum - comprimés pelliculés - olmesartanum medoxomilum 20.0 mg, hydrochlorothiazidum 25.0 mg, lactosum monohydricum 126.05 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 1.386 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-HCT-Mepha Teva 40/12.5 mg Comprimés pelliculés Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 40/12.5 mg comprimés pelliculés

mepha pharma ag - hydrochlorothiazidum - comprimés pelliculés - olmesartanum medoxomilum 40.0 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 289.60 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.772 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), e 110 0.007 mg, pro compresso obducto. - essentielle hypertonie - synthetika

Olmesartan-HCT-Mepha Teva 40/25 mg Comprimés pelliculés Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 40/25 mg comprimés pelliculés

mepha pharma ag - hydrochlorothiazidum - comprimés pelliculés - olmesartanum medoxomilum 40.0 mg, hydrochlorothiazidum 25.0 mg, lactosum monohydricum 277.10 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.772 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essentielle hypertonie - synthetika